Clinical Trial Update: L-Theanine in the Management of Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update indicating completion of a study evaluating L-Theanine in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• L-theanine (L-theanine)

Snippet

Sponsor: Sha'ar Menashe Mental Health Center | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED